DNM2 and early-onset autosomal dominant Alzheimer disease: We also found strong associations with GFAP, an astrocytic cytoskeletal protein that signals neurodegeneration and correlates with disability19, and P-Tau181, which is a marker of early Alzheimer’s disease-related neuropathological change52–55.